Primary mucosal melanoma.

Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol (2012) 1.64

Mucosal melanomas: a case-based review of the literature. Oncologist (2010) 1.20

Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol (2009) 1.18

Melanocytes are deficient in repair of oxidative DNA damage and UV-induced photoproducts. Proc Natl Acad Sci U S A (2010) 1.11

Pathogenesis, diagnosis and management of primary melanoma of the colon. World J Surg Oncol (2011) 0.98

A case of oral mucosal melanoma. Clinical and dermoscopic correlation. J Dermatol Case Rep (2012) 0.87

Melanoma of the Oral Cavity: an Analysis of 46 New Cases with Emphasis on Clinical and Histopathologic Characteristics. Head Neck Pathol (2016) 0.86

Primary malignant melanoma of uterine cervix FIGO IIa1: A case report with 40 months ongoing survival and literature review. Gynecol Oncol Case Rep (2013) 0.85

Mucosal melanomas in the elderly: challenging cases and review of the literature. Clin Interv Aging (2014) 0.82

Oral malignant melanoma: A case report with review of literature. Contemp Clin Dent (2014) 0.81

Incidence, Surgical Treatment, and Prognosis of Anorectal Melanoma From 1973 to 2011: A Population-Based SEER Analysis. Medicine (Baltimore) (2016) 0.81

Collision tumor of primary laryngeal mucosal melanoma and invasive squamous cell carcinoma with IL-17A and CD70 gene over-expression. Head Neck Pathol (2010) 0.80

Malignant melanoma of sun-protected sites: a review of clinical, histological, and molecular features. Lab Invest (2017) 0.80

Coexisting malignant melanoma and blue nevus of the uterine cervix: an unusual combination. Case Rep Pathol (2012) 0.79

Expression of Sox10 and c-kit in sinonasal mucosal melanomas arising in the Chinese population. Head Neck Pathol (2012) 0.79

Evaluation of the prognostic impact of postoperative adjuvant radiotherapy on head and neck mucosal melanoma: a meta-analysis. BMC Cancer (2015) 0.78

Cytomorphology of cervicovaginal melanoma: ThinPrep versus conventional Papanicolaou tests. Cytojournal (2010) 0.78

Metastatic mucosal melanoma: imaging patterns of metastasis and recurrence. Cancer Imaging (2013) 0.78

Melanoma epidemiology, biology and prognosis. EJC Suppl (2013) 0.78

Metastatic urethral melanoma: case report and review of the literature. Rev Urol (2014) 0.77

[The primary melanoma of the female genital tract: report of three cases and review of literature]. Pan Afr Med J (2013) 0.77

Chinese Guidelines on the Diagnosis and Treatment of Melanoma (2015 Edition). Ann Transl Med (2015) 0.76

Melanocytic Nevus on the Rectal Mucosa Removed Using Endoscopic Submucosal Dissection. Clin Endosc (2016) 0.75

[Malignant melanoma of the nasal cavity]. Pan Afr Med J (2012) 0.75

Non-cutaneous melanoma: is there a role for (18)F-FDG PET-CT? Br J Radiol (2014) 0.75

Sinonasal Melanoma: A Case Report and Literature Review. Case Rep Oncol Med (2017) 0.75

Metastases of Melanoma to Head and Neck Mucosa: A Report of Short Series. Clin Exp Otorhinolaryngol (2016) 0.75

Uterine cervical melanoma presenting with rapid progression detected by PET/CT. Acta Radiol Short Rep (2012) 0.75

Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients. Medicine (Baltimore) (2017) 0.75

Primary malignant mucosal melanoma of the upper lip: a case report and review of the literature. BMC Res Notes (2015) 0.75

A Case of Malignant Melanoma of the Uterine Cervix with Disseminated Metastases throughout the Vaginal Wall. Case Rep Obstet Gynecol (2017) 0.75

PTEN loss confers BRAF inhibitor resistance to melanoma cells through the suppression of BIM expression. Cancer Res (2011) 4.80

Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest (2004) 4.27

Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol (2008) 2.88

Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Ann Surg Oncol (2008) 2.11

Paradoxical oncogenesis--the long-term effects of BRAF inhibition in melanoma. Nat Rev Clin Oncol (2013) 1.77

Proper margins of excision in dermatofibrosarcoma protuberans: wide or narrow? Ann Surg Oncol (2008) 1.42

Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer Res (2008) 1.41

Lymphangiogenesis: host and tumor factors in nodal metastasis. Arch Dermatol (2008) 1.38

Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus. Clin Vaccine Immunol (2011) 1.35

Dermatofibrosarcoma protuberans: how wide should we resect? Ann Surg Oncol (2010) 1.35

Radiotherapy influences local control in patients with desmoplastic melanoma. Cancer (2013) 1.23

Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma. Lab Invest (2003) 1.23

The diagnosis, staging, and treatment options for mycosis fungoides. Cancer Control (2007) 1.17

Cutaneous melanoma: prognostic factors. Cancer Control (2005) 1.13

Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanoma. Ann Surg Oncol (2012) 1.11

Cutaneous angiosarcoma: a single-institution experience. Ann Surg Oncol (2013) 1.09

Generation of a tumor spheroid in a microgravity environment as a 3D model of melanoma. In Vitro Cell Dev Biol Anim (2009) 1.04

Case-control study of cutaneous human papillomaviruses in squamous cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev (2012) 1.04

Useof anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma. Am J Dermatopathol (2010) 1.02

Case-control study of Merkel cell polyomavirus infection and cutaneous squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2011) 1.02

Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma. Melanoma Res (2009) 1.02

Cutaneous protothecosis: a case report and review of the literature. Cutis (2007) 1.00

Pediatric melanoma: a review. Cancer Control (2009) 1.00

Sentinel lymph node biopsy for melanoma: indications and rationale. Cancer Control (2009) 0.99

Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST. Am J Surg Pathol (2016) 0.99

Shave biopsy is a safe and accurate method for the initial evaluation of melanoma. J Am Coll Surg (2011) 0.98

Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma. J Clin Oncol (2013) 0.98

Routine omission of sentinel lymph node biopsy for merkel cell carcinoma <= 1 cm is not justified. J Clin Oncol (2009) 0.98

Merkel cell carcinoma of unknown primary origin. Ann Surg Oncol (2012) 0.97

Uncommon manifestations of common malignancies: case 3. Malignant melanoma arising from a spinal nerve root. J Clin Oncol (2004) 0.97

Desmoplastic melanoma: is there a role for sentinel lymph node biopsy? Ann Surg Oncol (2013) 0.96

Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma. Cancer Epidemiol (2013) 0.96

Topical corticosteroids in dermatology. J Drugs Dermatol (2009) 0.95

Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature. Leuk Res (2011) 0.95

Sentinel node biopsy for thin melanomas: which patients should be considered? Cancer Control (2005) 0.94

Surgical management of melanoma in situ on chronically sun-damaged skin. Cancer Control (2008) 0.93

Case-control study of smoking and non-melanoma skin cancer. Cancer Causes Control (2011) 0.93

Pathology review of thin melanoma and melanoma in situ in a multidisciplinary melanoma clinic: impact on treatment decisions. J Clin Oncol (2009) 0.93

Measures of cutaneous human papillomavirus infection in normal tissues as biomarkers of HPV in corresponding nonmelanoma skin cancers. Int J Cancer (2008) 0.92

The unique clinical characteristics of melanoma diagnosed in children. Ann Surg Oncol (2012) 0.91

Case-control study of genus-beta human papillomaviruses in plucked eyebrow hairs and cutaneous squamous cell carcinoma. Int J Cancer (2013) 0.91

Concordance of human papillomavirus types detected on the surface and in the tissue of genital lesions in men. J Med Virol (2013) 0.90

Aquagenic syringeal acrokeratoderma: report of a case with histologic findings. J Am Acad Dermatol (2006) 0.90

Cutaneous human papillomavirus types detected on the surface of male external genital lesions: a case series within the HPV Infection in Men Study. J Clin Virol (2013) 0.88

Inhibition of autophagy enhances the effects of the AKT inhibitor MK-2206 when combined with paclitaxel and carboplatin in BRAF wild-type melanoma. Pigment Cell Melanoma Res (2014) 0.88

GSK3β inhibition blocks melanoma cell/host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation. J Invest Dermatol (2012) 0.87

Case-control study of cutaneous human papillomavirus infection in Basal cell carcinoma of the skin. J Invest Dermatol (2013) 0.87

Pediatric melanoma: analysis of an international registry. Cancer (2013) 0.86

Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm. Ann Surg Oncol (2012) 0.85

Emergence of a squamous cell carcinoma phenotype following treatment of metastatic basal cell carcinoma with vismodegib. J Am Acad Dermatol (2013) 0.85

Current status of biomarkers for melanoma metastasis. IDrugs (2006) 0.84

Merkel cell carcinoma: a clinical, histopathologic, and immunohistochemical review. Semin Cutan Med Surg (2004) 0.84

Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery. Dermatol Surg (2009) 0.84

Reticular erythematous mucinosis--a review. Int J Dermatol (2012) 0.84

Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach. Cancer Res (2013) 0.84

Sunlight exposure and cutaneous human papillomavirus seroreactivity in basal cell and squamous cell carcinomas of the skin. J Infect Dis (2012) 0.84

Patterns and timing of sunlight exposure and risk of basal cell and squamous cell carcinomas of the skin--a case-control study. BMC Cancer (2012) 0.83

Proliferative activity, chromosomal aberrations, and tumor-specific mutations in the differential diagnosis between blue nevi and melanoma. Am J Pathol (2012) 0.83

Merkel cell carcinoma: pathologic findings and prognostic factors. Curr Probl Cancer (2010) 0.83

Immunohistochemical stains in Mohs surgery: a review. Dermatol Surg (2009) 0.83

Gene variants in angiogenesis and lymphangiogenesis and cutaneous melanoma progression. Cancer Epidemiol Biomarkers Prev (2013) 0.82

CD4/CD8 dual-positive mycosis fungoides: a previously unrecognized variant. Am J Dermatopathol (2012) 0.82

Sentinel lymph node biopsy as the standard of care for cutaneous melanoma. Clin Adv Hematol Oncol (2007) 0.82

Utility of sentinel lymphadenectomy in the management of patients with high-risk cutaneous squamous cell carcinoma. Dermatol Surg (2003) 0.82

Sentinel lymph node biopsy is indicated for patients with thick clinically lymph node-negative melanoma. Cancer (2015) 0.82

Controversies in the evaluation and management of atypical melanocytic proliferations in children, adolescents, and young adults. J Natl Compr Canc Netw (2013) 0.81

Meeting report from the 2011 International Melanoma Congress, Tampa, Florida. Pigment Cell Melanoma Res (2011) 0.81

Molecular bases of cutaneous and uveal melanomas. Patholog Res Int (2011) 0.81

Desmoplastic nevus: An entity distinct from spitz nevus and blue nevus. Am J Dermatopathol (2011) 0.80

Multiple keratoacanthomas arising in the setting of sorafenib therapy: novel chemoprophylaxis with bexarotene. Cancer Control (2009) 0.80

Treatment of locally metastatic melanoma: a novel approach. J Drugs Dermatol (2007) 0.79

Completely regressed cutaneous melanocytic lesion revisited. Semin Oncol (2009) 0.78

Sentinel node biopsy in atypical melanocytic neoplasms in childhood: a single institution experience in 24 patients. J Cutan Pathol (2012) 0.78

Recent advances in pathologic evaluation and reporting of melanoma. Semin Oncol (2012) 0.78

The impact of neoadjuvant hedgehog inhibitor therapy on the surgical treatment of extensive basal cell carcinoma. Ann Plast Surg (2015) 0.77

Primary cutaneous angioimmunoblastic T-cell lymphoma histologically mimicking an inflammatory dermatosis. J Drugs Dermatol (2010) 0.77

Expression of CXCR4, E-cadherin, Bcl-2, and survivin in Merkel cell carcinoma: an immunohistochemical study using a tissue microarray. Am J Dermatopathol (2012) 0.77

Optimum treatment strategies for actinic keratosis (intraepidermal squamous cell carcinoma). Am J Clin Dermatol (2004) 0.77

Measurement of constitutive MAPK and PI3K/AKT signaling activity in human cancer cell lines. Methods Enzymol (2010) 0.77

Primary tumor thickness as a prognostic factor in Merkel cell carcinoma: the next big thing? Ann Surg Oncol (2012) 0.76

Unanswered questions in the management of stage I-III Merkel cell carcinoma. J Natl Compr Canc Netw (2014) 0.76

A collision of diseases: chronic lymphocytic leukemia discovered during lymph node biopsy for melanoma. Ann Surg Oncol (2012) 0.76

Cutaneous leiomyosarcoma: treatment and outcomes with a standardized margin of resection. Cancer Control (2013) 0.76

Identifying risk factors using a skin cancer screening program. Cancer Control (2013) 0.75

Reassessing the role of lymphatic mapping and sentinel lymphadenectomy in the management of cutaneous malignant melanoma. J Am Acad Dermatol (2003) 0.75

Treatment of Head and Neck Melanoma In Situ With Staged Contoured Marginal Excisions. Ann Plast Surg (2016) 0.75

Is there a true concern regarding the use of hair dye and malignancy development?: a review of the epidemiological evidence relating personal hair dye use to the risk of malignancy. J Clin Aesthet Dermatol (2013) 0.75

Refining the criteria for sentinel lymph node biopsy in patients with thinner melanoma: a roadmap for the future. Cancer (2010) 0.75

In vitro adherence of lymphocytes to dermal endothelium under shear stress: implications in pathobiology and steroid therapy of acute cutaneous GVHD. Blood (2002) 0.75